Emmecell
PrivateLast Round
Strategic
Jun 16, 2026
Total Funding Raised
$46M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Emmecell is a biotechnology company that develops cell-based therapies for the treatment of eye diseases using its proprietary Magnetic Cell Delivery (MCD) nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emmecell Comparables
Compare Emmecell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trefoil Therapeutics | 81% | |
| ActualEyes, Inc. | 80% | |
| Cellusion Inc. | 80% |
Emmecell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 16, 2026 | ||||
| Series A | Jan 19, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 101% MoM, reaching 3.2K.
- Jan 23, 2026
Monthly visitors grew 71% MoM, reaching 2.2K.
Recent news
Latest coverage and updates
- recognized_asJul 13, 2026
Emmecell recognized as FDA Regenerative Medicine Advanced Therapy (RMAT) designation for EO2002 on Jul 13th '26.
Emmecell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Emmecell's valuation, stock price, and market status.
Is Emmecell a public or private company?
Emmecell is a private company.
What is the current stock price of Emmecell?
Emmecell is a private company with no public stock price. No recent secondary market data is available.
How much is Emmecell worth (valuation)?
Valuation information for Emmecell is not publicly available.
Can I buy Emmecell stock?
Emmecell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Emmecell's last funding round?
Funding round information for Emmecell is not publicly available.
Who are the main investors in Emmecell?
Investor information for Emmecell is not publicly disclosed.
Will Emmecell IPO soon?
No public IPO plans have been announced for Emmecell.
How can I track Emmecell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Emmecell's secondary market activity and sign up for updates.